Nkarta (NKTX) Other Working Capital Changes (2022 - 2026)
Nkarta (NKTX) posted quarterly Other Working Capital Changes of -$1.4 million for Q1 2026, down 4.26% year-over-year from -$1.5 million in Q1 2025, and down 3.5% quarter-over-quarter from -$1.4 million in Q4 2025.
Nkarta (NKTX) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Nkarta's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 4.26% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at -$5.1 million (up 23.36% YoY), while the FY2025 annual figure was -$5.0 million, up 21.9% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.4 million, down from -$1.4 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.9 million in Q3 2022, with the low at -$1.8 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$430000.0 (2023), against an average of -$110176.5.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes surged 395.17% in 2023, then slumped 1438.71% in 2025.
- Nkarta's Other Working Capital Changes stood at $21.0 million in 2022, then sank by 105.36% to -$1.1 million in 2023, then sank by 161.72% to -$2.9 million in 2024, then surged by 53.44% to -$1.4 million in 2025, then decreased by 3.5% to -$1.4 million in 2026.
- Business Quant data shows NKTX's Other Working Capital Changes at -$1.4 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.46 Mn |
| Jun 30, 2026 | -1.46 Mn |
| Jun 30, 2026 | -1.46 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Sep 30, 2025 | -1.91 Mn |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Mar 31, 2025 | -1.36 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Dec 31, 2024 | -2.95 Mn |